The Work We Fund

Funded projects
Men's Health Partners
We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact.
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programmes
Mental health and suicide prevention
“The number of men taking their own lives around the world is one of the biggest challenges of our time. Movember is working to ensure all men and boys look after their mental health and are comfortable to seek help when they’re struggling.”
Brendan Maher, Global Director, Mental Health and Suicide Prevention.
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programmes.

GAP4 Prostate Cancer Exercise and Metabolic Health

Movember Funding to Date

EUR 164,961

What we seek to achieve

The GAP4 Project will determine if intense exercise and psychosocial support increases overall survival compared to psychosocial support alone in patients with metastatic prostate cancer. Biomarkers and molecular mechanisms underpinning the effects of exercise will also be explored.The primary endpoint for the study is overall survival at 3 years. Secondary endpoints include quality of life and clinically meaningful indicators.

Implemented by
The Movember Foundation
Project start date
September 2013
Project Status
In Progress

About the project

  • Through a global collaboration, GAP4 will execute a large-scale, multi-centred and multi-national trial designed to test the effects of exercise on prostate cancer progression and treatment side effects.  
  • The project will be underpinned by a global translational research initiative which aims to better understand the biological mechanisms of action of exercise on prostate cancer.
  • Patient data and biological samples will be shared and studied across the world by leading scientists and clinicians.
  • Possible links between the GAP1 Biomarker Initiative and the results of this project will be explored.
  • The GAP4 project will be designed by a Steering Committee and will then be implemented by participating clinical centres worldwide.
This project is governed by the GAP4 Project Research Advisory Committee.  This advisory committee of highly regarded experts in the field have guided and shaped the project with the Movember Global Scientific Committee from its inception.

Page 1 of 28